VERU INC. Common Stock, Value, Issued
VERU INC. (VERU) had Common Stock, Value, Issued of $172.69 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-10
- 2026-06-30: Common Stock, Value, Issued $172.69K.
- 2026-03-31: Common Stock, Value, Issued $162.69K.
- 2025-12-31: Common Stock, Value, Issued $162.69K.
- 2025-09-30: Common Stock, Value, Issued $148.69K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $172.69K 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $162.69K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $162.69K 10-Q · filed 2026-02-11 | |
| 2025-09-30 | $148.69K 10-Q · filed 2026-08-10 | |
| 2025-06-30 | $148.69K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $1.49M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $1.49M 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $148.57K 10-K · filed 2025-12-17 | $1.49M 10-K · filed 2024-12-16 |
| 2024-06-30 | $1.49M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.49M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $1.49M 10-Q · filed 2024-04-01 | |
| 2023-09-30 | $939.66K 10-K · filed 2024-12-16 | |
| 2023-06-30 | $914.20K 10-Q/A · filed 2023-11-15 | |
| 2023-03-31 | $847.61K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $828.07K 10-Q · filed 2023-02-09 | |
| 2022-09-30 | $826.93K 10-K/A · filed 2024-04-01 | |
| 2022-06-30 | $823.12K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $822.50K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $822.33K 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $821.53K 10-K · filed 2022-12-05 | |
| 2021-06-30 | $820.38K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $818.67K 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $740.91K 10-Q · filed 2021-02-10 | |
| 2020-09-30 | $720.47K 10-K · filed 2021-12-02 | |
| 2020-06-30 | $720.47K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $678.79K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $672.23K 10-Q · filed 2020-02-12 | |
| 2019-09-30 | $672.22K 10-K · filed 2020-12-10 | |
| 2019-06-30 | $670.02K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $649.68K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $648.01K 10-Q · filed 2019-02-13 | |
| 2018-09-30 | $574.69K 10-K · filed 2019-12-12 | |
| 2018-06-30 | $569.28K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $556.97K 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $556.97K 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $553.92K 10-K · filed 2018-12-13 | |
| 2017-06-30 | $335.22K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $335.22K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $335.22K 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $312.74K 10-K · filed 2018-01-02 | |
| 2016-06-30 | $312.36K 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $312.19K 10-Q · filed 2016-04-28 | |
| 2015-12-31 | $312.07K 10-Q · filed 2016-02-02 | |
| 2015-09-30 | $311.93K 10-K · filed 2016-12-12 | |
| 2015-06-30 | $309.95K 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $309.98K 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $310.01K 10-Q · filed 2015-02-03 | |
| 2014-09-30 | $309.59K 10-K · filed 2015-12-02 | |
| 2014-06-30 | $309.25K 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $308.95K 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $308.45K 10-Q · filed 2014-02-03 | |
| 2013-09-30 | $306.95K 10-K · filed 2014-12-02 | |
| 2013-06-30 | $306.97K 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $306.54K 10-Q · filed 2013-05-02 | |
| 2012-12-31 | $306.54K 10-Q · filed 2013-01-30 | |
| 2012-09-30 | $305.50K 10-K · filed 2013-12-03 | |
| 2012-06-30 | $298.34K 10-Q · filed 2012-07-31 | |
| 2012-03-31 | $298.37K 10-Q · filed 2012-05-01 | |
| 2011-12-31 | $298.23K 10-Q · filed 2012-01-31 | |
| 2011-09-30 | $296.49K 10-K · filed 2012-12-04 | |
| 2011-06-30 | $296.49K 10-Q · filed 2011-08-05 | |
| 2010-09-30 | $293.68K 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |